Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:associated_with |
gptkb:T-cell_leukemia
|
| gptkbp:clinical_trial |
ongoing research for treatment options
|
| gptkbp:discovered_by |
gptkb:1990
|
| gptkbp:distribution |
gptkb:South_America
Central Africa |
| gptkbp:emphasizes |
gp21
gp46 |
| gptkbp:genus |
Deltaretrovirus
|
| gptkbp:healthcare |
screening initiatives
education and awareness programs in endemic regions |
| https://www.w3.org/2000/01/rdf-schema#label |
HTLV-4
|
| gptkbp:is_protected_by |
safe sex practices
avoidance of breastfeeding by infected mothers screening of blood donors |
| gptkbp:is_vulnerable_to |
risk assessment studies
no vaccine available prevalence in specific populations transmission dynamics research |
| gptkbp:number_of_cores |
p19
p24 |
| gptkbp:nutritional_value |
gptkb:Retroviridae
|
| gptkbp:promoter |
Rev protein
Tax protein |
| gptkbp:propagation_method |
breastfeeding
sexual contact blood transfusion |
| gptkbp:related_to |
gptkb:HTLV-1
gptkb:HTLV-2 |
| gptkbp:replaced_by |
a patient in Cameroon
|
| gptkbp:research_focus |
treatment strategies
epidemiology studies HIV co-infection |
| gptkbp:risk_factor |
immunosuppression
co-infection with other viruses |
| gptkbp:seed_dispersal |
approximately 9 kb
|
| gptkbp:social_responsibility |
gptkb:adult_T-cell_leukemia/lymphoma
serological testing PCR testing HTLV-associated myelopathy anti-HTLV-4 antibodies tropical spastic paraparesis |
| gptkbp:symptoms |
dermatitis
asymptomatic infection myelopathy |
| gptkbp:transponders |
C D4+ T cells
C D8+ T cells |
| gptkbp:treatment |
gptkb:vaccine
gptkb:drug chemotherapy no specific antiviral treatment |
| gptkbp:bfsParent |
gptkb:Deltaretrovirinae
gptkb:HTLV-1 |
| gptkbp:bfsLayer |
5
|